Core Scientific (CORZ) Cash from Operations (2021 - 2026)

Core Scientific has disclosed Cash from Operations across 6 years of filings, most recently posting -$18.9 million for Q2 2026.

• In Q2 2026, Cash from Operations fell 155.67% year-over-year to -$18.9 million; the TTM figure through Jun 2026 stood at $520.2 million (up 6037.08% YoY), while the FY2025 annual figure was $278.2 million, up 548.66% from the prior year.
• Cash from Operations came in at -$18.9 million for Q2 2026 at Core Scientific, down from $249.9 million in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of $249.9 million in Q1 2026 to a low of -$52.1 million in Q3 2022.
• Average Cash from Operations over 5 years is $45.7 million, with a median of $19.0 million recorded in 2023.
• The largest YoY upside for Cash from Operations was 2723.92% in 2025 against a maximum downside of 303.13% in 2025.
• Over 5 years, Cash from Operations stood at $116.0 million in 2022, then sank by 81.29% to $21.7 million in 2023, then plunged by 36.39% to $13.8 million in 2024, then soared by 1040.96% to $157.5 million in 2025, then plunged by 112.02% to -$18.9 million in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were -$18.9 million in Q2 2026, $249.9 million in Q1 2026, and $157.5 million in Q4 2025.